| SCLAFANI, Francesco, Elisa FONTANA, Lucjan WYRWICZ, Anna Dorothea WAGNER, Juan W VALLE, Elizabeth SMYTH, Mark PEETERS, Radka OBERMANNOVÁ, Cindy NEUZILLET, Manfred P LUTZ, Thibaud KOESSLER, Irit BEN-AHARON, Dirk ARNOLD, Maria ALSINA and Markus MOEHLER. Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group. CLINICAL COLORECTAL CANCER. DALLAS: CIG MEDIA GROUP, LP, 2022, vol. 21, No 3, p. 188-197. ISSN 1533-0028. Available from: https://dx.doi.org/10.1016/j.clcc.2022.04.001. |
Other formats:
BibTeX
LaTeX
RIS
@article{2250977,
author = {Sclafani, Francesco and Fontana, Elisa and Wyrwicz, Lucjan and Wagner, Anna Dorothea and Valle, Juan W and Smyth, Elizabeth and Peeters, Mark and Obermannová, Radka and Neuzillet, Cindy and Lutz, Manfred P and Koessler, Thibaud and BenandAharon, Irit and Arnold, Dirk and Alsina, Maria and Moehler, Markus},
article_location = {DALLAS},
article_number = {3},
doi = {http://dx.doi.org/10.1016/j.clcc.2022.04.001},
keywords = {Clinical trials; Meeting; Esophago-gastric cancers; Hepato-pancreatico-biliary cancers; Colorectal cancers},
language = {eng},
issn = {1533-0028},
journal = {CLINICAL COLORECTAL CANCER},
title = {Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group},
url = {https://www.sciencedirect.com/science/article/pii/S1533002822000408?via%3Dihub},
volume = {21},
year = {2022}
}
TY - JOUR
ID - 2250977
AU - Sclafani, Francesco - Fontana, Elisa - Wyrwicz, Lucjan - Wagner, Anna Dorothea - Valle, Juan W - Smyth, Elizabeth - Peeters, Mark - Obermannová, Radka - Neuzillet, Cindy - Lutz, Manfred P - Koessler, Thibaud - Ben-Aharon, Irit - Arnold, Dirk - Alsina, Maria - Moehler, Markus
PY - 2022
TI - Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
JF - CLINICAL COLORECTAL CANCER
VL - 21
IS - 3
SP - 188-197
EP - 188-197
PB - CIG MEDIA GROUP, LP
SN - 15330028
KW - Clinical trials
KW - Meeting
KW - Esophago-gastric cancers
KW - Hepato-pancreatico-biliary cancers
KW - Colorectal cancers
UR - https://www.sciencedirect.com/science/article/pii/S1533002822000408?via%3Dihub
N2 - Recently, we have witnessed impressive diagnostic and therapeutic changes for gastrointestinal cancer patients. New challenges brought by the COVID-19 pandemic have led us to re-evaluate our work priorities. Thanks to the commendable resilience of both investigators and patients, however, clinical research never stopped. In addition to conducting cutting-edge research and serving patients' needs, as EORTC Gastrointestinal Tract Cancer Group, we are committed to pursuing educational initiatives beneficial to the entire European oncology community and beyond. In this regard, we have been providing critical discussions of new data from major international meetings. In this article, we discuss results of important selected studies presented at the 2022 ASCO Gastrointestinal Cancer Symposium, putting them in perspectives and highlighting potential implications for routine practice. With the number of in-person attendees and practice-changing/informing trials presented, this meeting represented a milestone in the return to normality as well as in the fight against cancer.
ER -
SCLAFANI, Francesco, Elisa FONTANA, Lucjan WYRWICZ, Anna Dorothea WAGNER, Juan W VALLE, Elizabeth SMYTH, Mark PEETERS, Radka OBERMANNOVÁ, Cindy NEUZILLET, Manfred P LUTZ, Thibaud KOESSLER, Irit BEN-AHARON, Dirk ARNOLD, Maria ALSINA and Markus MOEHLER. Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group. \textit{CLINICAL COLORECTAL CANCER}. DALLAS: CIG MEDIA GROUP, LP, 2022, vol.~21, No~3, p.~188-197. ISSN~1533-0028. Available from: https://dx.doi.org/10.1016/j.clcc.2022.04.001.
|
